Advanced search
Publication Cover
Cell Cycle Volume 11, 2012 - Issue 11
Submit an article Journal homepage
311
Views
27
CrossRef citations to date
0
Altmetric
Cell Cycle News & Views

A killer promoting survival: p53 as a selective means to avoid side effects of chemotherapy

Dominique Kranz German Cancer Research Center; Heidelberg, Germany
&
Matthias Dobbelstein Göttingen Center of Molecular Biosciences; University of Göttingen; Göttingen, GermanyCorrespondence[email protected]
Pages 2053-2054 | Received 25 Apr 2012, Accepted 09 May 2012, Published online: 01 Jun 2012
 
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Abstract

Comment on: van Leeuwen IMM, et al. Cell Cycle 2012; 11:1851-61.

Related Research Data

Nongenotoxic p53 activation protects cells against S-phase-specific chemotherapy.
Source: American Association for Cancer Research (AACR)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
Source: American Association for the Advancement of Science (AAAS)
Deciphering the molecular mechanism and apoptosis underlying the in-vitro and in-vivo chemotherapeutic efficacy of vanadium luteolin complex in colon cancer.
Source: Wiley
Ethanolic extract of Brucea javanica inhibit proliferation of HCT-116 colon cancer cells via caspase activation
Source: Royal Society of Chemistry (RSC)

Linking provided by 
Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.